Outcome |
16-week CR rate |
32-week CR rate |
CR time (weeks, median and
95%CI) |
1-year cumulative recurrence rate |
2-year cumulative
recurrence rate |
1-year cumulative pregnancy rate |
MA group |
25.6% (11/43) |
78.3% (36/46) |
29.2 (24.4-33.9) |
8.0% |
10.5% |
40.7% |
LNG-IUS group |
45.7% (21/46) |
82.7% (43/52) |
19.2 (16.1-21.8) |
3.7% |
7.2% |
37.5% |
MA+LNG-IUS group |
37.2% (16/43) |
79.2% (38/48) |
25.7 (17.0-34.4) |
2.1% |
4.8% |
38.5% |
Pa |
0.143 |
0.842 |
0.316 |
/ |
/ |
/ |
Pb |
0.049 |
0.580 |
0.118 |
/ |
/ |
/ |
Pc |
0.245 |
0.915 |
0.496 |
/ |
/ |
/ |
Pd |
0.419 |
0.653 |
0.471 |
/ |
/ |
/ |
OR/HRb (95%CI) |
2.44 (1.00-6.00) |
1.33
(0.49-3.62) |
1.34 (0.93-1.94) |
/ |
/ |
/ |
OR/HRc (95%CI) |
1.72 (0.69-4.34) |
1.06 (0.39-2.84) |
1.14 (0.78-1.66) |
/ |
/ |
/ |
OR/HRd (95%CI) |
0.71 (0.30-1.65) |
0.80
(0.29-2.16) |
0.87 (0.60-1.27) |
/ |
/ |
/ |